Latest Biotechnology, Pharmaceutical and Healthcare News

07:19 EST 26th November 2015 | BioPortfolio

Showing News Articles 1–25 of 410,000+

Thursday 26th November 2015

Renin angiotensinogen system gene polymorphisms and essential hypertension among people of West African descent: a systematic review

CMS Global Lifesciences Forum 2015 in Frankfurt tackles the industry's hottest topics

• There are major M&A opportunities in the lifesciences industry, particularly in the fragmented medical device sector • eHealth and mHealth devices and apps are changing the way patients interact with their doctors and medicine • Big data has great potential to help the medical industry, but must overcome data protection risks before being fully utilised • Changes to ...

Major European Biopharma uses G:BOX Chemi XX6 Image Analyser To Accurately Characterise Large Therapeutic Proteins

Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is pleased to announce its G:BOX Chemi XX6 multi-application-functionalimager is being utilised by scientists at major human protein R&D company, Octapharma Biopharmaceuticals GmbH in Germany for analysing a range of largeproteins. This is allowing the researchers there to accurately characterise proteins&...

UK Chancellor presents spending plans for health

UK Chancellor presents spending plans for health

Selection bias in clinical trials and other stories . . .

Our drug works well for highly selected MartiansClinical trials are supposed to inform clinical practice. If they don’t, they become ethically questionable. One of the biggest problems is selection...

Pay in the NHS: who earns what?

Healthcare has always been a labour intensive industry and is likely to remain so. In a study of the probability of computerisation of different occupations, along with choreographers, computer...

The statistical sins of Jeremy Hunt

The health secretary for England, Jeremy Hunt, has been criticised recently over his handling of statistics. Although it can be easy to make statistical errors, his handling of the so called “weekend...

Sixty seconds on . . . ADHD

Attention-deficit/hyperactivity disorder? That’s a diagnosis in search of a disease, isn’t it?Not according to most child psychiatrists, who say that there is plenty of evidence that it’s a real...

Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?

Serological and proteomic biomarkers can help clinicians diagnose rheumatic diseases earlier and assess disease activity more accurately. These markers have been incorporated into the recently...

Unconscious bias harms patients and staff

Human bias can be defined as a disposition to think, feel, or act in a particular way. It may stem from longstanding personality attributes, from particular sets of knowledge or past experience, or...

BRIEF-Top Choice Medical Investment plans acquisitions via share issue

* Says plans to acquire stakes in medical technology firm, investment JVs' assets for 5.05 billion yuan ($790.36 million) via share issue

Stem Cell Liver cell therapies closer as study reveals key to mass production

SOURCE 25 November 2015 Stem cell scientists have made a key find that aids the quest to produce therapies for patients with liver damage. They have developed a new technique for growing liver cells from stem cells that is cost-effective and could be adapted for mass production of clinical grade […]

BRIEF-Co.Don successfully completes capital increase

* Increases share capital of co.don AG to 16,217,344 euros Source text for Eikon: Further company coverage: ($1 = 0.9429 euros) (Gdynia Newsroom)

Phase III failure for Pfizer's Lyrica in new indication

Phase III failure for Pfizer's Lyrica in new indication

TU Delft: Developing Surgical Tools for Snaking Through The Body

SOURCE November 25, 2015 On a recent tour of medtech scene in Holland, we stopped off at TU Delft where teams of professors and graduate students are designing tools to improve how various surgical techniques are performed. Just like we are at Medgadget, the folks at TU Delft believe that […]

GSK begins Phase III study of sirukumab in giant cell arteritis

GSK today announced it has begun a Phase III study evaluating sirukumab, a human anti-interleukin (IL)-6 monoclonal antibody, for the treatment of patients with giant cell arteritis (GCA). GCA is a disease characterised by inflammation of large and medium sized arteries predominantly in the head and neck. It almost exclusively occurs in people aged 50 years or over, (most commonly in patients aged...

Shire prepares new Baxalta bid

Following rejection in an earlier bid, it has emerged that Shire is preparing a new takeover offer for US biotech firm Baxalta, which saw a considerable share jump after reports emerged quoting a source familiar with the matter. If successful, the acquisition is set to create one of the world’s leading rare disease specialists, paving the way for advanced treatment in such conditions, with sales...

BRIEF-Boehringer says Pradaxa reversal agent approved in EU

* Boehringer Ingelheim says Praxbind (idarucizumab) approved in European Union for the specific reversal of Pradaxa

COUCHAGE du NOURRISSON: Le strict minimum dans le lit du bébé - Pediatrics

Aucun accessoire mou, y compris un tour de lit, ne devrait être placé dans le lit du bébé, rappelle, une nouvelle fois, cette étude de l'Université de Washington. « Les tours de lit tuent les enfants », alerte l'auteur principal de cette étude qui révèle une augmentation des morts inattendues de nourrissons associ&...

BRIEF-Food Standard Agency gives positive opinion on Pharmena's 1-MNA authorization motion

* Food Standard Agency gives positive opinion on company's motion on 1-MNA authorization as new food ingredient

EKF Diagnostics tumbles on impairment warning

EKF Diagnostics (LON:EKF) shares crashed as it warned of significant impairment charges following a review of the business by its new chairman. Ron Zwanziger, a veteran of many medical companies and who took over two weeks ago, said full year reven...

Researchers question use of methylphenidate for ADHD patients

Clinicians cannot know for sure whether taking methylphenidate will improve the lives of children with ADHD because of the quality of the available evidence, according to the lead author of a Cochrane Review.

A pharmacy initiative to tackle men’s health

On every measure of health, men fare significantly worse than women. Most of us are aware of Movember and how it raises public awareness of some of the biggest health issues faced by men. Since 2003, this men’s health movement has raised £402m and funded more than 1,000 programmes, focusing on the biggest male health threats, with prostate cancer leading the list and this year physical inactivi...

Four Men and Women Have 10,000 Extra Reasons to Be Thankful after Winning $10,000 in National Health Challenge

Eric Scott of Omaha, Neb.; Danielle Gee of Humble, Texas; Chuck Tanner of Cary, N.C.; and Rachel Winston of Summerlin, Nev. all have 10,000 extra reasons to be thankful this holiday season after learning they were the winners of $10,000 in a national 90-Day Weight Loss and Transformation Challenge. Based on their significant weight loss or transformation, ...

Evolucumab draft recommendations

The National Institute for Health and Care Excellence (NICE) has issued draft guidance not recommending evolocumab (Repatha, Amgen) as an option for people with high cholesterol (primary hypercholesterolaemia — heterozygous-familial and non-familial) and mixed dyslipidaemia. The draft guidance can be accessed


BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.